| Serial Number | 90596751 |
| Word Mark | CRISPR BY DESIGN |
| Filing Date | Tuesday, March 23, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, February 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 21, 2022 |
| Goods and Services | Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeuticsin the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics in the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders |
| Goods and Services | Molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes; Medical diagnostic testing services in the field of human disease and human medical conditions |
| Disclaimer with Predetermined Text | "CRISPR" |
| Goods and Services | Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Event Date | Event Description |
| Friday, February 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 8, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, February 8, 2024 | SOU EXTENSION 3 FILED |
| Thursday, February 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Saturday, August 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 10, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, August 10, 2023 | SOU EXTENSION 2 FILED |
| Thursday, August 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, February 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 8, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 8, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, February 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 16, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 21, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 21, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 1, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, May 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 26, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 26, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 26, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 28, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 28, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, October 28, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 27, 2021 | ASSIGNED TO EXAMINER |
| Monday, June 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 26, 2021 | NEW APPLICATION ENTERED |